Literature DB >> 25833525

Taurine Targets the GluN2b-Containing NMDA Receptor Subtype.

Christopher Y Chan1, Inderbir Singh, Heather Magnuson, Mohammad Zohaib, Kalindi P Bakshi, Brice Le François, Ana Anazco-Ayala, Eung Jeon Lee, Andrew Tom, Kristel YeeMon, Andre Ragnauth, Eitan Friedman, Shailesh P Banerjee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25833525     DOI： 10.1007/978-3-319-15126-7_43

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  3 in total

Review 1.  Taurine as an Essential Neuromodulator during Perinatal Cortical Development.

Authors:  Werner Kilb; Atsuo Fukuda
Journal:  Front Cell Neurosci       Date:  2017-10-24       Impact factor: 5.505

2.  Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress.

Authors:  Azliana Jusnida Ahmad Jafri; Renu Agarwal; Igor Iezhitsa; Puneet Agarwal; Alexander Spasov; Alexander Ozerov; Nafeeza Mohd Ismail
Journal:  Mol Vis       Date:  2018-07-25       Impact factor: 2.367

3.  New solutions for old challenges in glaucoma treatment: is taurine an option to consider?

Authors:  Igor Iezhitsa; Renu Agarwal
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.